Selegiline Hydrochloride

CAS 14611-52-0 4 current records 8 historicalSmall Molecule

Who holds supplier records for Selegiline Hydrochloride? 4 organisations hold a current record for Selegiline Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Italy (1), Hungary (1), Germany (1) and China (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Selegiline Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/selegiline-hydrochloride

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Selegiline Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Selegiline Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Selegiline Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 6 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ANHUI BIOCHEM PHARMACEUTICAL CO., LTD. FuyangCN
CEP 2024-459 - Rev 00
Selegiline hydrochloride
Sept 2025—
DIPHARMA FRANCIS S.R.L. BaranzateIT
R0-CEP 2023-056 - Rev 00
Selegiline hydrochloride, S2
Apr 2023—
EUROAPI HUNGARY Ltd. BudapestHU
R1-CEP 1998-014 - Rev 04
Selegiline hydrochloride
Dec 2021—
SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH MindenDE
R1-CEP 1999-124 - Rev 04
Selegiline hydrochloride
Dec 2015—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (8)

Organisations whose Type II DMFs for Selegiline Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 8 historical records
  • Czechia · Inactive DMF 31024 · filed Oct 2016
  • RESOLUTION CHEMICALS LTD
    Inactive DMF 11356 · filed Feb 1995
  • SIEGFRIED LTD
    Inactive DMF 11104 · filed Sept 1994
  • IROTEC LABORATORIES
    Inactive DMF 10529 · filed Oct 1993
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 10235 · filed May 1993
  • ARENOL CHEMICAL CORP
    Inactive DMF 10036 · filed Dec 1992
  • ALCHYMARS SPA
    Inactive DMF 9734 · filed Jun 1992
  • WYCKOFF CHEMICAL CO INC
    Inactive DMF 9230 · filed Jul 1991

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Selegiline Hydrochloride is a selective monoamine oxidase B (MAO-B) inhibitor primarily used in the treatment of Parkinson's disease. It may also be used in the treatment of major depressive disorder.

Chemical identity

IUPAC name
(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine;hydrochloride
Canonical SMILES
C[C@H](CC1=CC=CC=C1)N(C)CC#C.Cl
InChIKey
IYETZZCWLLUHIJ-UTONKHPSSA-N
Synonyms
Eldepryl API, eldepryl, ensam, l-deprenyl, nsc-759259, selegiline hcl, zelapar

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Monoamine Oxidase Inhibitor; Monoamine Oxidase Type B Inhibitor
Mechanism of action
Monoamine Oxidase Inhibitors; Monoamine Oxidase-B Inhibitors

Therapeutic areas

NeurologyPsychiatry

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Selegiline Hydrochloride?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Selegiline Hydrochloride: Dipharma Francis Srl (Italy), EUROAPI HUNGARY LTD (Hungary), SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH (Germany) and ANHUI BIOCHEM PHARMACEUTICAL CO., LTD. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Selegiline Hydrochloride Drug Master Files are active?

Dipharma Francis Srl (DMF 9275) and EUROAPI HUNGARY LTD (DMF 5161). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Selegiline Hydrochloride records mean?

8 organisations have only inactive Type II DMFs for Selegiline Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Selegiline Hydrochloride have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Selegiline Hydrochloride on the EDQM register, including ANHUI BIOCHEM PHARMACEUTICAL CO., LTD. Fuyang (CN), DIPHARMA FRANCIS S.R.L. Baranzate (IT), EUROAPI HUNGARY Ltd. Budapest (HU) and SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH Minden (DE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Selegiline Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Selegiline Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.